These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evaluation of a rat model of experimental autoimmune encephalomyelitis with human MBP as antigen. Guo L; Li Y; Lin H; Ji X; Li J; Que L; Zhang Y; Rong Y; Wang J Cell Mol Immunol; 2004 Oct; 1(5):387-91. PubMed ID: 16285900 [TBL] [Abstract][Full Text] [Related]
30. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Ziemssen T; Ziemssen F Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612 [TBL] [Abstract][Full Text] [Related]
31. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery. Samoilova EB; Horton JL; Chen Y Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation. Stojkov D; Lavrnja I; Pekovic S; Dacic S; Bjelobaba I; Mostarica-Stojkovic M; Stosic-Grujicic S; Jovanovic S; Nedeljkovic N; Rakic L; Stojiljkovic M J Neurol Sci; 2008 Apr; 267(1-2):76-85. PubMed ID: 17996253 [TBL] [Abstract][Full Text] [Related]
33. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system. Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893 [TBL] [Abstract][Full Text] [Related]
34. FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis. Balatoni B; Storch MK; Swoboda EM; Schönborn V; Koziel A; Lambrou GN; Hiestand PC; Weissert R; Foster CA Brain Res Bull; 2007 Oct; 74(5):307-16. PubMed ID: 17845905 [TBL] [Abstract][Full Text] [Related]
35. Lessons from multiple sclerosis: models, concepts, observations. Wekerle H Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii56-60. PubMed ID: 19022815 [TBL] [Abstract][Full Text] [Related]
36. Microwave and magnetic (M(2) ) proteomics of the experimental autoimmune encephalomyelitis animal model of multiple sclerosis. Raphael I; Mahesula S; Kalsaria K; Kotagiri V; Purkar AB; Anjanappa M; Shah D; Pericherla V; Jadhav YL; Raghunathan R; Vaynberg M; Noriega D; Grimaldo NH; Wenk C; Gelfond JA; Forsthuber TG; Haskins WE Electrophoresis; 2012 Dec; 33(24):3810-9. PubMed ID: 23161666 [TBL] [Abstract][Full Text] [Related]
37. How can proteomics elucidate the complexity of multiple sclerosis? Farias AS; Santos LM Proteomics Clin Appl; 2015 Oct; 9(9-10):844-7. PubMed ID: 25980360 [TBL] [Abstract][Full Text] [Related]
38. The more the merrier? Scoring, statistics and animal welfare in experimental autoimmune encephalomyelitis. Palle P; Ferreira FM; Methner A; Buch T Lab Anim; 2016 Dec; 50(6):427-432. PubMed ID: 27909192 [TBL] [Abstract][Full Text] [Related]
39. Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis. Dagley LF; Emili A; Purcell AW Proteomics Clin Appl; 2013 Jan; 7(1-2):91-108. PubMed ID: 23112123 [TBL] [Abstract][Full Text] [Related]
40. Osteopontin as a two-sided mediator in acute neuroinflammation in rat models. Shin T Acta Histochem; 2012 Dec; 114(8):749-54. PubMed ID: 22947282 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]